Convatec Group PLC

Pre-Annual General Meeting Information • Mar 16, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3304G

ConvaTec Group PLC

16 March 2020

2019 Annual Report & Accounts and

Notice of Annual General Meeting

READING, UNITED KINGDOM (16 March 2020) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a global medical products and technologies company, today announces that the following documents are now available on its website at www.convatecgroup.com.

-     2019 Annual Report & Accounts

-     Notice of 2020 Annual General Meeting

In compliance with Listing Rule 9.6.1, copies of the Annual Report and Notice of AGM have also been submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

Printed copies of these documents will be sent to shareholders who have requested hard copies in due course.

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations, ConvaTec           +44 (0)7551 036 625

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Haynes          +44 (0)207 466 5000                                                                                                 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACSEQLFFBXLXBBB